ProCE Banner Activity

Update: Adjuvant Therapy for Patients With HR+/HER2- EBC at High Risk of Recurrence

Slideset Download
Download this slideset on the expert’s overview of adjuvant treatment for patients with HR+/HER2- early breast cancer at high risk of recurrence.

Released: July 02, 2021

Expiration: July 01, 2022

No longer available for credit.

Share

Faculty

Stephen R. D. Johnston

Stephen R. D. Johnston, MA, FRCP, PhD

Professor of Breast Cancer Medicine
Breast Unit
Department of Medicine
Royal Marsden Hospital
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Lilly

Faculty Disclosure

Primary Author

Stephen R. D. Johnston, MA, FRCP, PhD

Professor of Breast Cancer Medicine
Breast Unit
Department of Medicine
Royal Marsden Hospital
London, United Kingdom